 | • レポートコード：MRC2-11QY11519 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は新型コロナウイルス感染症診断検査のグローバル市場について調査・分析したレポートです。種類別（核酸検査、抗体検査）市場規模、用途別（病院、科学研究）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別新型コロナウイルス感染症診断検査の競争状況、市場シェア ・世界の新型コロナウイルス感染症診断検査市場：種類別市場規模 2015年-2020年（核酸検査、抗体検査） ・世界の新型コロナウイルス感染症診断検査市場：種類別市場規模予測 2021年-2026年（核酸検査、抗体検査） ・世界の新型コロナウイルス感染症診断検査市場：用途別市場規模 2015年-2020年（病院、科学研究） ・世界の新型コロナウイルス感染症診断検査市場：用途別市場規模予測 2021年-2026年（病院、科学研究） ・北米の新型コロナウイルス感染症診断検査市場分析：米国、カナダ ・ヨーロッパの新型コロナウイルス感染症診断検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの新型コロナウイルス感染症診断検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の新型コロナウイルス感染症診断検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの新型コロナウイルス感染症診断検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cellex、Abbott、Roche、BioMedomics、BD、Henry Schein、Safecare Bio-Tech、Mayo Clinic Laboratories、Chembio Diagnostics、Mount Sinai Laboratory、Ortho Clinical Diagnostics、Zhejiang Orient Gene Biotech、Innovita Biological Technology、Guangzhou Wondfo Biotech、Guangdong Hecin-Scientific、Dynamiker Biotechnology (Tianjin)、ADVAITE ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Market Analysis and Insights: Global COVID-19 Diagnostic Testing Market
The global COVID-19 Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global COVID-19 Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global COVID-19 Diagnostic Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global COVID-19 Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global COVID-19 Diagnostic Testing market.
Global COVID-19 Diagnostic Testing Scope and Market Size
COVID-19 Diagnostic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Nucleic Acid Testing
Antibody Testing
Market segment by Application, split into
Hospitals
Scientific Research
Based on regional and country-level analysis, the COVID-19 Diagnostic Testing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global COVID-19 Diagnostic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Nucleic Acid Testing
1.2.3 Antibody Testing
1.3 Market by Application
1.3.1 Global COVID-19 Diagnostic Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Diagnostic Testing Market Perspective (2015-2026)
2.2 Global COVID-19 Diagnostic Testing Growth Trends by Regions
2.2.1 COVID-19 Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 COVID-19 Diagnostic Testing Historic Market Share by Regions (2015-2020)
2.2.3 COVID-19 Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Diagnostic Testing Players by Market Size
3.1.1 Global Top COVID-19 Diagnostic Testing Players by Revenue (2015-2020)
3.1.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Players (2015-2020)
3.2 Global COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Diagnostic Testing Revenue
3.4 Global COVID-19 Diagnostic Testing Market Concentration Ratio
3.4.1 Global COVID-19 Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnostic Testing Revenue in 2019
3.5 Key Players COVID-19 Diagnostic Testing Area Served
3.6 Key Players COVID-19 Diagnostic Testing Product Solution and Service
3.7 Date of Enter into COVID-19 Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Diagnostic Testing Breakdown Data by Type (2015-2026)
4.1 Global COVID-19 Diagnostic Testing Historic Market Size by Type (2015-2020)
4.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2021-2026)
5 COVID-19 Diagnostic Testing Breakdown Data by Application (2015-2026)
5.1 Global COVID-19 Diagnostic Testing Historic Market Size by Application (2015-2020)
5.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America COVID-19 Diagnostic Testing Market Size (2015-2026)
6.2 North America COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
6.3 North America COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
6.4 North America COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe COVID-19 Diagnostic Testing Market Size (2015-2026)
7.2 Europe COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
7.3 Europe COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
7.4 Europe COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China COVID-19 Diagnostic Testing Market Size (2015-2026)
8.2 China COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
8.3 China COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
8.4 China COVID-19 Diagnostic Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan COVID-19 Diagnostic Testing Market Size (2015-2026)
9.2 Japan COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
9.3 Japan COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
9.4 Japan COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia COVID-19 Diagnostic Testing Market Size (2015-2026)
10.2 Southeast Asia COVID-19 Diagnostic Testing Market Size by Type (2015-2020)
10.3 Southeast Asia COVID-19 Diagnostic Testing Market Size by Application (2015-2020)
10.4 Southeast Asia COVID-19 Diagnostic Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Details
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 Diagnostic Testing Introduction
11.1.4 Cellex Revenue in COVID-19 Diagnostic Testing Business (2015-2020))
11.1.5 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Diagnostic Testing Introduction
11.2.4 Abbott Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 Diagnostic Testing Introduction
11.3.4 Roche Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.3.5 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Details
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 Diagnostic Testing Introduction
11.4.4 BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.4.5 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD COVID-19 Diagnostic Testing Introduction
11.5.4 BD Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.5.5 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Details
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 Diagnostic Testing Introduction
11.6.4 Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.6.5 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Details
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.7.5 Safecare Bio-Tech Recent Development
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Details
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Introduction
11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.8.5 Mayo Clinic Laboratories Recent Development
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Details
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Introduction
11.9.4 Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.9.5 Chembio Diagnostics Recent Development
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Details
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Introduction
11.10.4 Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
11.10.5 Mount Sinai Laboratory Recent Development
11.11 Ortho Clinical Diagnostics
10.11.1 Ortho Clinical Diagnostics Company Details
10.11.2 Ortho Clinical Diagnostics Business Overview
10.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Introduction
10.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
10.12.1 Zhejiang Orient Gene Biotech Company Details
10.12.2 Zhejiang Orient Gene Biotech Business Overview
10.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Introduction
10.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
10.13.1 Innovita Biological Technology Company Details
10.13.2 Innovita Biological Technology Business Overview
10.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Introduction
10.13.4 Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
10.14.1 Guangzhou Wondfo Biotech Company Details
10.14.2 Guangzhou Wondfo Biotech Business Overview
10.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Introduction
10.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
10.15.1 Guangdong Hecin-Scientific Company Details
10.15.2 Guangdong Hecin-Scientific Business Overview
10.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Introduction
10.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
10.16.1 Dynamiker Biotechnology (Tianjin) Company Details
10.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
10.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Introduction
10.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
10.17.1 ADVAITE Company Details
10.17.2 ADVAITE Business Overview
10.17.3 ADVAITE COVID-19 Diagnostic Testing Introduction
10.17.4 ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2015-2020)
10.17.5 ADVAITE Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Nucleic Acid Testing
Table 4. Key Players of Antibody Testing
Table 5. Global COVID-19 Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global COVID-19 Diagnostic Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global COVID-19 Diagnostic Testing Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global COVID-19 Diagnostic Testing Market Share by Regions (2015-2020)
Table 9. Global COVID-19 Diagnostic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global COVID-19 Diagnostic Testing Market Share by Regions (2021-2026)
Table 11. COVID-19 Diagnostic Testing Market Market Trends
Table 12. COVID-19 Diagnostic Testing Market Drivers
Table 13. COVID-19 Diagnostic Testing Market Challenges
Table 14. COVID-19 Diagnostic Testing Market Restraints
Table 15. Global COVID-19 Diagnostic Testing Revenue by Players (2015-2020) (US$ Million)
Table 16. Global COVID-19 Diagnostic Testing Market Share by Players (2015-2020)
Table 17. Global Top COVID-19 Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COVID-19 Diagnostic Testing as of 2019)
Table 18. Global COVID-19 Diagnostic Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players COVID-19 Diagnostic Testing Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global COVID-19 Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 23. Global COVID-19 Diagnostic Testing Market Size Share by Type (2015-2020)
Table 24. Global COVID-19 Diagnostic Testing Revenue Market Share by Type (2021-2026)
Table 25. Global COVID-19 Diagnostic Testing Market Size Share by Application (2015-2020)
Table 26. Global COVID-19 Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 27. Global COVID-19 Diagnostic Testing Market Size Share by Application (2021-2026)
Table 28. North America COVID-19 Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 29. North America COVID-19 Diagnostic Testing Market Share by Type (2015-2020)
Table 30. North America COVID-19 Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 31. North America COVID-19 Diagnostic Testing Market Share by Application (2015-2020)
Table 32. North America COVID-19 Diagnostic Testing Market Size by Country (US$ Million) (2015-2020)
Table 33. North America COVID-19 Diagnostic Testing Market Share by Country (2015-2020)
Table 34. Europe COVID-19 Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe COVID-19 Diagnostic Testing Market Share by Type (2015-2020)
Table 36. Europe COVID-19 Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe COVID-19 Diagnostic Testing Market Share by Application (2015-2020)
Table 38. Europe COVID-19 Diagnostic Testing Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe COVID-19 Diagnostic Testing Market Share by Country (2015-2020)
Table 40. China COVID-19 Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 41. China COVID-19 Diagnostic Testing Market Share by Type (2015-2020)
Table 42. China COVID-19 Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 43. China COVID-19 Diagnostic Testing Market Share by Application (2015-2020)
Table 44. China COVID-19 Diagnostic Testing Market Size by Region (US$ Million) (2015-2020)
Table 45. China COVID-19 Diagnostic Testing Market Share by Region (2015-2020)
Table 46. Japan COVID-19 Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan COVID-19 Diagnostic Testing Market Share by Type (2015-2020)
Table 48. Japan COVID-19 Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan COVID-19 Diagnostic Testing Market Share by Application (2015-2020)
Table 50. Japan COVID-19 Diagnostic Testing Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan COVID-19 Diagnostic Testing Market Share by Country (2015-2020)
Table 52. Southeast Asia COVID-19 Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia COVID-19 Diagnostic Testing Market Share by Type (2015-2020)
Table 54. Southeast Asia COVID-19 Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia COVID-19 Diagnostic Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia COVID-19 Diagnostic Testing Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia COVID-19 Diagnostic Testing Market Share by Country (2015-2020)
Table 58. Cellex Company Details
Table 59. Cellex Business Overview
Table 60. Cellex Product
Table 61. Cellex Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 62. Cellex Recent Development
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Product
Table 66. Abbott Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 67. Abbott Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Product
Table 71. Roche Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 72. Roche Recent Development
Table 73. BioMedomics Company Details
Table 74. BioMedomics Business Overview
Table 75. BioMedomics Product
Table 76. BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 77. BioMedomics Recent Development
Table 78. BD Company Details
Table 79. BD Business Overview
Table 80. BD Product
Table 81. BD Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 82. BD Recent Development
Table 83. Henry Schein Company Details
Table 84. Henry Schein Business Overview
Table 85. Henry Schein Product
Table 86. Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 87. Henry Schein Recent Development
Table 88. Safecare Bio-Tech Company Details
Table 89. Safecare Bio-Tech Business Overview
Table 90. Safecare Bio-Tech Product
Table 91. Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 92. Safecare Bio-Tech Recent Development
Table 93. Mayo Clinic Laboratories Business Overview
Table 94. Mayo Clinic Laboratories Product
Table 95. Mayo Clinic Laboratories Company Details
Table 96. Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 97. Mayo Clinic Laboratories Recent Development
Table 98. Chembio Diagnostics Company Details
Table 99. Chembio Diagnostics Business Overview
Table 100. Chembio Diagnostics Product
Table 101. Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 102. Chembio Diagnostics Recent Development
Table 103. Mount Sinai Laboratory Company Details
Table 104. Mount Sinai Laboratory Business Overview
Table 105. Mount Sinai Laboratory Product
Table 106. Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 107. Mount Sinai Laboratory Recent Development
Table 108. Ortho Clinical Diagnostics Company Details
Table 109. Ortho Clinical Diagnostics Business Overview
Table 110. Ortho Clinical Diagnostics Product
Table 111. Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 112. Ortho Clinical Diagnostics Recent Development
Table 113. Zhejiang Orient Gene Biotech Company Details
Table 114. Zhejiang Orient Gene Biotech Business Overview
Table 115. Zhejiang Orient Gene Biotech Product
Table 116. Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 117. Zhejiang Orient Gene Biotech Recent Development
Table 118. Innovita Biological Technology Company Details
Table 119. Innovita Biological Technology Business Overview
Table 120. Innovita Biological Technology Product
Table 121. Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 122. Innovita Biological Technology Recent Development
Table 123. Guangzhou Wondfo Biotech Company Details
Table 124. Guangzhou Wondfo Biotech Business Overview
Table 125. Guangzhou Wondfo Biotech Product
Table 126. Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 127. Guangzhou Wondfo Biotech Recent Development
Table 128. Guangdong Hecin-Scientific Company Details
Table 129. Guangdong Hecin-Scientific Business Overview
Table 130. Guangdong Hecin-Scientific Product
Table 131. Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 132. Guangdong Hecin-Scientific Recent Development
Table 133. Dynamiker Biotechnology (Tianjin) Company Details
Table 134. Dynamiker Biotechnology (Tianjin) Business Overview
Table 135. Dynamiker Biotechnology (Tianjin) Product
Table 136. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 137. Dynamiker Biotechnology (Tianjin) Recent Development
Table 138. ADVAITE Company Details
Table 139. ADVAITE Business Overview
Table 140. ADVAITE Product
Table 141. ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2015-2020) (US$ Million)
Table 142. ADVAITE Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Diagnostic Testing Market Share by Type: 2020 VS 2026
Figure 2. Nucleic Acid Testing Features
Figure 3. Antibody Testing Features
Figure 4. Global COVID-19 Diagnostic Testing Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Scientific Research Case Studies
Figure 7. COVID-19 Diagnostic Testing Report Years Considered
Figure 8. Global COVID-19 Diagnostic Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 9. Global COVID-19 Diagnostic Testing Market Share by Regions: 2020 VS 2026
Figure 10. Global COVID-19 Diagnostic Testing Market Share by Regions (2021-2026)
Figure 11. Global COVID-19 Diagnostic Testing Market Share by Players in 2019
Figure 12. Global Top COVID-19 Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COVID-19 Diagnostic Testing as of 2019
Figure 13. The Top 10 and 5 Players Market Share by COVID-19 Diagnostic Testing Revenue in 2019
Figure 14. North America COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 15. United States COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. Canada COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Europe COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Germany COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. France COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. U.K. COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Italy COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Russia COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Nordic COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Rest of Europe COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Asia-Pacific COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. China COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Japan COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. South Korea COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Southeast Asia COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. India COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Australia COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Asia-Pacific COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Latin America COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Mexico COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Brazil COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Middle East & Africa COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Turkey COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Saudi Arabia COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. UAE COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Middle East & Africa COVID-19 Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Cellex Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 42. Abbott Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 43. Roche Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 44. BioMedomics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 45. BD Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 46. Henry Schein Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 47. Safecare Bio-Tech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 48. Mayo Clinic Laboratories Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 49. Chembio Diagnostics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 50. Mount Sinai Laboratory Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 51. Ortho Clinical Diagnostics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 52. Zhejiang Orient Gene Biotech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 53. Innovita Biological Technology Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 54. Guangzhou Wondfo Biotech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 55. Guangdong Hecin-Scientific Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 56. Dynamiker Biotechnology (Tianjin) Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 57. ADVAITE Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
豚診断検査の世界市場（～2026年） Swine diagnostic testing is extremely important for pork breeders to keep adverse effects on production and minimum economic losses. Growing consumption of pork meat is expected to be the prime factor driving the growth of global swine diagnostic testing market. Market Analysis and Insights: Global …- IVD（体外診断）検査の世界市場（～2026年） In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorp…
- 免疫タンパク質診断検査の世界市場（～2026年） Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiova…
- 子宮がん診断検査の世界市場（～2026年） Uterus a female organ also referred as the womb is located in the lower abdomen. It supports in the fetal development until birth. In North America, the U.S. is expected to be the dominant market for uterine cancer diagnostic testing due to growing incidence of uterine cancer. Market Analysis and In…
- 骨・ミネラル診断検査の世界市場（～2026年） Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsib…